FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:624-630 August 29, 1996 Number 9 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Restenosis occurs commonly after coronary angioplasty and atherectomy, but the causes of restenosis are poorly understood. Recently, it has been found that cytomegalovirus (CMV) DNA is present in restenotic lesions from atherectomy specimens. This and other evidence suggest that CMV may have a role in the process of restenosis.

Methods We prospectively studied 75 consecutive patients undergoing directional coronary atherectomy for symptomatic coronary artery disease. Before atherectomy was performed, we measured blood levels of anti-CMV IgG antibodies to determine whether previous exposure to CMV increased the risk of restenosis, as determined by coronary angiography performed six months after atherectomy.

Results After atherectomy, the mean (±SD) minimal luminal diameter of the target vessel was greater in the 49 patients who were seropositive for CMV than in the 26 patients who were seronegative (3.18±0.51 mm vs. 2.89±0.45 mm, P = 0.01). After six months, however, the seropositive patients had a greater reduction in the luminal diameter (1.24±0.83 mm vs. 0.68±0.69 mm, P = 0.003), resulting in a significantly higher rate of restenosis in the seropositive patients (43 percent vs. 8 percent, P = 0.002). In a multivariable logistic-regression model, CMV seropositivity and the CMV titer were independently predictive of restenosis (odds ratios, 12.9 and 8.1, respectively). There was no evidence of acute infection, since the titer of anti-CMV IgG antibodies did not increase over time and tests for anti-CMV IgM antibodies were negative in all patients.

Conclusions Prior infection with CMV is a strong independent risk factor for restenosis after coronary atherectomy. If confirmed, these findings may help identify patients at risk for restenosis.

Source Information

From the Cardiology Branch, National Heart, Lung, and Blood Institute, Bethesda, Md. (Y.F.Z., M.A.W., Z.X.Y., T.F., S.E.E.), and the Washington Hospital Center, Washington, D.C. (M.B.L., J.J.P.).

Address reprint requests to Dr. Epstein at the Cardiology Branch, National Heart, Lung, and Blood Institute, Bldg. 10, Rm. 7B15, 10 Center Dr., MSC 1650, Bethesda, MD 20892-1650.

Full Text of this Article

Related Letters:

Association between Prior Cytomegalovirus Infection and the Risk of Restenosis after Coronary Atherectomy
Smith K., Parsonnet J., Kol A., Sperti G., Maseri A., Zhou Y. F., Waclawiw M. A., Epstein S. E.
Extract | Full Text  
N Engl J Med 1997; 336:587-588, Feb 20, 1997. Correspondence

This article has been cited by other articles:

• Simanek, A. M, Dowd, J. B., Aiello, A. E (2009). Persistent pathogens linking socioeconomic position and cardiovascular disease in the US. Int J Epidemiol 38: 775-787 [Abstract] [Full Text]  
• Qian, Z., Xuan, B., Hong, T. T., Yu, D. (2008). The Full-Length Protein Encoded by Human Cytomegalovirus Gene UL117 Is Required for the Proper Maturation of Viral Replication Compartments. J. Virol. 82: 3452-3465 [Abstract] [Full Text]  
• Michaelis, M., Ha, T. A. T., Doerr, H. W., Cinatl, J. Jr (2008). Valproic acid interferes with antiviral treatment in human cytomegalovirus-infected endothelial cells. Cardiovasc Res 77: 544-550 [Abstract] [Full Text]  
• Bolovan-Fritts, C. A., Spector, S. A. (2008). Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interaction. Blood 111: 175-182 [Abstract] [Full Text]  
• Krebs, P., Scandella, E., Bolinger, B., Engeler, D., Miller, S., Ludewig, B. (2007). Chronic Immune Reactivity Against Persisting Microbial Antigen in the Vasculature Exacerbates Atherosclerotic Lesion Formation. Arterioscler. Thromb. Vasc. Bio. 27: 2206-2213 [Abstract] [Full Text]  
• Bolovan-Fritts, C. A., Trout, R. N., Spector, S. A. (2007). High T-cell response to human cytomegalovirus induces chemokine-mediated endothelial cell damage. Blood 110: 1857-1863 [Abstract] [Full Text]  
• Sanz-Gonzalez, S. M., Barquin, L., Garcia-Cao, I., Roque, M., Gonzalez, J. M., Fuster, J. J., Castells, M. T., Flores, J. M., Serrano, M., Andres, V. (2007). Increased p53 gene dosage reduces neointimal thickening induced by mechanical injury but has no effect on native atherosclerosis. Cardiovasc Res 75: 803-812 [Abstract] [Full Text]  
• Shen, P., Niu, G., Yao, M., Wang, H., Fei, J. (2007). Studying on the 19-bp Palindrome Repeats in Human Cytomegalovirus Immediate Early Enhancer/Promoter Reveals their Diversity in Function for the Promoter Activity. J Biochem 142: 25-31 [Abstract] [Full Text]  
• Terhune, S., Torigoi, E., Moorman, N., Silva, M., Qian, Z., Shenk, T., Yu, D. (2007). Human Cytomegalovirus UL38 Protein Blocks Apoptosis. J. Virol. 81: 3109-3123 [Abstract] [Full Text]  
• Bentz, G. L., Jarquin-Pardo, M., Chan, G., Smith, M. S., Sinzger, C., Yurochko, A. D. (2006). Human Cytomegalovirus (HCMV) Infection of Endothelial Cells Promotes Naive Monocyte Extravasation and Transfer of Productive Virus To Enhance Hematogenous Dissemination of HCMV. J. Virol. 80: 11539-11555 [Abstract] [Full Text]  
• Yang, X., Murthy, V., Schultz, K., Tatro, J. B., Fitzgerald, K. A., Beasley, D. (2006). Toll-like receptor 3 signaling evokes a proinflammatory and proliferative phenotype in human vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 291: H2334-H2343 [Abstract] [Full Text]  
• Reinhardt, B., Winkler, M., Schaarschmidt, P., Pretsch, R., Zhou, S., Vaida, B., Schmid-Kotsas, A., Michel, D., Walther, P., Bachem, M., Mertens, T. (2006). Human cytomegalovirus-induced reduction of extracellular matrix proteins in vascular smooth muscle cell cultures: a pathomechanism in vasculopathies?. J. Gen. Virol. 87: 2849-2858 [Abstract] [Full Text]  
• Sanchez, V., Spector, D. H. (2006). Cyclin-Dependent Kinase Activity Is Required for Efficient Expression and Posttranslational Modification of Human Cytomegalovirus Proteins and for Production of Extracellular Particles.. J. Virol. 80: 5886-5896 [Abstract] [Full Text]  
• Froberg, M. K., Dannen, D., Adams, A., Parker-Thornburg, J., Kolattukudy, P. (2006). Murine Cytomegalovirus Infection Markedly Reduces Serum MCP-1 Levels in MCP-1 Transgenic Mice.. Annals of Clinical & Laboratory Science 36: 179-184 [Abstract] [Full Text]  
• Shen, Y. H., Zhang, L., Utama, B., Wang, J., Gan, Y., Wang, X., Wang, J., Chen, L., Vercellotti, G. M., Coselli, J. S., Mehta, J. L., Wang, X. L. (2006). Human cytomegalovirus inhibits Akt-mediated eNOS activation through upregulating PTEN (phosphatase and tensin homolog deleted on chromosome 10). Cardiovasc Res 69: 502-511 [Abstract] [Full Text]  
• Ryckman, B. J., Jarvis, M. A, Drummond, D. D., Nelson, J. A., Johnson, D. C. (2006). Human Cytomegalovirus Entry into Epithelial and Endothelial Cells Depends on Genes UL128 to UL150 and Occurs by Endocytosis and Low-pH Fusion. J. Virol. 80: 710-722 [Abstract] [Full Text]  
• Walsh, D., Perez, C., Notary, J., Mohr, I. (2005). Regulation of the Translation Initiation Factor eIF4F by Multiple Mechanisms in Human Cytomegalovirus-Infected Cells. J. Virol. 79: 8057-8064 [Abstract] [Full Text]  
• Oshima, T., Ozono, R., Yano, Y., Oishi, Y., Teragawa, H., Higashi, Y., Yoshizumi, M., Kambe, M. (2005). Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol 45: 1219-1222 [Abstract] [Full Text]  
• Rahbar, A., Soderberg-Naucler, C. (2005). Human Cytomegalovirus Infection of Endothelial Cells Triggers Platelet Adhesion and Aggregation. J. Virol. 79: 2211-2220 [Abstract] [Full Text]  
• Casarosa, P., Waldhoer, M., LiWang, P. J., Vischer, H. F., Kledal, T., Timmerman, H., Schwartz, T. W., Smit, M. J., Leurs, R. (2005). CC and CX3C Chemokines Differentially Interact with the N Terminus of the Human Cytomegalovirus-encoded US28 Receptor. J. Biol. Chem. 280: 3275-3285 [Abstract] [Full Text]  
• Reinhardt, B., Schaarschmidt, P., Bossert, A., Luske, A., Finkenzeller, G., Mertens, T., Michel, D. (2005). Upregulation of functionally active vascular endothelial growth factor by human cytomegalovirus. J. Gen. Virol. 86: 23-30 [Abstract] [Full Text]  
• Bolovan-Fritts, C. A., Trout, R. N., Spector, S. A. (2004). Human Cytomegalovirus-Specific CD4+-T-Cell Cytokine Response Induces Fractalkine in Endothelial Cells. J. Virol. 78: 13173-13181 [Abstract] [Full Text]  
• Reeves, M. B., Coleman, H., Chadderton, J., Goddard, M., Sissons, J. G. P., Sinclair, J. H. (2004). Vascular endothelial and smooth muscle cells are unlikely to be major sites of latency of human cytomegalovirus in vivo. J. Gen. Virol. 85: 3337-3341 [Abstract] [Full Text]  
• Evers, D. L., Komazin, G., Ptak, R. G., Shin, D., Emmer, B. T., Townsend, L. B., Drach, J. C. (2004). Inhibition of Human Cytomegalovirus Replication by Benzimidazole Nucleosides Involves Three Distinct Mechanisms. Antimicrob. Agents Chemother. 48: 3918-3927 [Abstract] [Full Text]  
• Toutouzas, K., Colombo, A., Stefanadis, C. (2004). Inflammation and restenosis after percutaneous coronary interventions. Eur Heart J 25: 1679-1687 [Abstract] [Full Text]  
• Ludewig, B., Krebs, P., Scandella, E. (2004). Immunopathogenesis of atherosclerosis. J. Leukoc. Biol. 76: 300-306 [Abstract] [Full Text]  
• Leis, M., Marschall, M., Stamminger, T. (2004). Downregulation of the cellular adhesion molecule Thy-1 (CD90) by cytomegalovirus infection of human fibroblasts. J. Gen. Virol. 85: 1995-2000 [Abstract] [Full Text]  
• Shen, Y.H., Utama, B., Wang, J., Raveendran, M., Senthil, D., Waldman, W.J., Belcher, J.D., Vercellotti, G., Martin, D., Mitchelle, B.M., Wang, X.L. (2004). Human Cytomegalovirus Causes Endothelial Injury Through the Ataxia Telangiectasia Mutant and p53 DNA Damage Signaling Pathways. Circ. Res. 94: 1310-1317 [Abstract] [Full Text]  
• Froberg, M. K. (2004). CMV Escapes!. Annals of Clinical & Laboratory Science 34: 123-130 [Abstract] [Full Text]  
• Nerheim, P. L., Meier, J. L., Vasef, M. A., Li, W.-G., Hu, L., Rice, J. B., Gavrila, D., Richenbacher, W. E., Weintraub, N. L. (2004). Enhanced Cytomegalovirus Infection in Atherosclerotic Human Blood Vessels. Am. J. Pathol. 164: 589-600 [Abstract] [Full Text]  
• Mnjoyan, Z. H., Dutta, R., Zhang, D., Teng, B.-B., Fujise, K. (2003). Paradoxical Upregulation of Tumor Suppressor Protein p53 in Serum-Stimulated Vascular Smooth Muscle Cells: A Novel Negative-Feedback Regulatory Mechanism. Circulation 108: 464-471 [Abstract] [Full Text]  
• Lin, T-M, Chen, W-j, Chen, H-Y, Wang, P-W, Eng, H-L (2003). Increased incidence of cytomegalovirus but not Chlamydia pneumoniae in atherosclerotic lesions of arteries of lower extremities from patients with diabetes mellitus undergoing amputation. J. Clin. Pathol. 56: 429-432 [Abstract] [Full Text]  
• Smieja, M., Gnarpe, J., Lonn, E., Gnarpe, H., Olsson, G., Yi, Q., Dzavik, V., McQueen, M., Yusuf, S., for the Heart Outcomes Prevention Evaluation (HOPE, (2003). Multiple Infections and Subsequent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 107: 251-257 [Abstract] [Full Text]  
• Horne, B. D., Muhlestein, J. B., Carlquist, J. F., Bair, T. L., Madsen, T. E., Hart, N. I., Anderson, J. L., for the Intermountain Heart Collaborative (IHC) St, (2003). Statin Therapy Interacts With Cytomegalovirus Seropositivity and High C-Reactive Protein in Reducing Mortality Among Patients With Angiographically Significant Coronary Disease. Circulation 107: 258-263 [Abstract] [Full Text]  
• Kronschnabl, M., Stamminger, T. (2003). Synergistic induction of intercellular adhesion molecule-1 by the human cytomegalovirus transactivators IE2p86 and pp71 is mediated via an Sp1-binding site. J. Gen. Virol. 84: 61-73 [Abstract] [Full Text]  
• Maisch, T., Kropff, B., Sinzger, C., Mach, M. (2002). Upregulation of CD40 Expression on Endothelial Cells Infected with Human Cytomegalovirus. J. Virol. 76: 12803-12812 [Abstract] [Full Text]  
• Suzuki, K., Murtuza, B., Suzuki, N., Khan, M., Kaneda, Y., Yacoub, M. H. (2002). Human Cytomegalovirus Immediate-Early Protein IE2-86, but not IE1-72, Causes Graft Coronary Arteriopathy in the Transplanted Rat Heart. Circulation 106: I-158-I-162 [Abstract] [Full Text]  
• Prasad, A., Zhu, J., Halcox, J. P.J., Waclawiw, M. A., Epstein, S. E., Quyyumi, A. A. (2002). Predisposition to Atherosclerosis by Infections: Role of Endothelial Dysfunction. Circulation 106: 184-190 [Abstract] [Full Text]  
• Fortunato, E. A., Sanchez, V., Yen, J. Y., Spector, D. H. (2002). Infection of Cells with Human Cytomegalovirus during S Phase Results in a Blockade to Immediate-Early Gene Expression That Can Be Overcome by Inhibition of the Proteasome. J. Virol. 76: 5369-5379 [Abstract] [Full Text]  
• Mulvihill, N T, Foley, J B (2002). Inflammation in acute coronary syndromes. Heart 87: 201-204 [Abstract] [Full Text]  
• Sanchez, V., Clark, C. L., Yen, J. Y., Dwarakanath, R., Spector, D. H. (2002). Viable Human Cytomegalovirus Recombinant Virus with an Internal Deletion of the IE2 86 Gene Affects Late Stages of Viral Replication. J. Virol. 76: 2973-2989 [Abstract] [Full Text]  
• Hansson, G. K. (2001). Immune Mechanisms in Atherosclerosis. Arterioscler. Thromb. Vasc. Bio. 21: 1876-1890 [Abstract] [Full Text]  
• Agema, W. R. P., Jukema, J. W., Pimstone, S. N., Kastelein, J. J. P. (2001). Genetic aspects of restenosis after percutaneous coronary interventions;towards more tailored therapy. Eur Heart J 22: 2058-2074  
• George, J., Greenberg, S., Barshack, I., Singh, M., Pri-Chen, S., Laniado, S., Keren, G. (2001). Accelerated intimal thickening in carotid arteries of balloon-injured rats after immunization against heat shock protein 70. J Am Coll Cardiol 38: 1564-1569 [Abstract] [Full Text]  
• Buerger, I., Reefschlaeger, J., Bender, W., Eckenberg, P., Popp, A., Weber, O., Graeper, S., Klenk, H.-D., Ruebsamen-Waigmann, H., Hallenberger, S. (2001). A Novel Nonnucleoside Inhibitor Specifically Targets Cytomegalovirus DNA Maturation via the UL89 and UL56 Gene Products. J. Virol. 75: 9077-9086 [Abstract] [Full Text]  
• Neumann, F.-J., Kastrati, A., Miethke, T., Mehilli, J., Pogatsa-Murray, G., Koch, W., Seyfarth, M., Schomig, A. (2001). Previous Cytomegalovirus Infection and Restenosis After Coronary Stent Placement. Circulation 104: 1135-1139 [Abstract] [Full Text]  
• DIEZ-JUAN, A., ANDRES, V. (2001). The growth suppressor p27Kip1 protects against diet-induced atherosclerosis. FASEB J. 15: 1989-1995 [Abstract] [Full Text]  
• Blankenberg, S., Rupprecht, H. J., Bickel, C., Espinola-Klein, C., Rippin, G., Hafner, G., Ossendorf, M., Steinhagen, K., Meyer, J. (2001). Cytomegalovirus Infection With Interleukin-6 Response Predicts Cardiac Mortality in Patients With Coronary Artery Disease. Circulation 103: 2915-2921 [Abstract] [Full Text]  
• Zhu, J., Shearer, G. M., Marincola, F. M., Norman, J. E., Rott, D., Zou, J.-P., Epstein, S. E. (2001). Discordant cellular and humoral immune responses to cytomegalovirus infection in healthy blood donors: existence of a Th1-type dominant response. Int Immunol 13: 785-790 [Abstract] [Full Text]  
• Patel, N. H., Jindal, R. M., Wilkin, T., Rose, S., Johnson, M. S., Shah, H., Namyslowski, J., Moresco, K. P., Trerotola, S. O. (2001). Renal Arterial Stenosis in Renal Allografts: Retrospective Study of Predisposing Factors and Outcome after Percutaneous Transluminal Angioplasty. Radiology 219: 663-667 [Abstract] [Full Text]  
• Froberg, M. K., Seacotte, N., Dahlberg, E. (2001). Cytomegalovirus Seropositivity and Serum Total Cholesterol Levels in Young Patients. Annals of Clinical & Laboratory Science 31: 157-161 [Abstract] [Full Text]  
• BRENNAN, D. C. (2001). Cytomegalovirus in Renal Transplantation. J. Am. Soc. Nephrol. 12: 848-855 [Full Text]  
• Burian, K., Kis, Z., Virok, D., Endresz, V., Prohaszka, Z., Duba, J., Berencsi, K., Boda, K., Horvath, L., Romics, L., Fust, G., Gonczol, E. (2001). Independent and Joint Effects of Antibodies to Human Heat-Shock Protein 60 and Chlamydia pneumoniae Infection in the Development of Coronary Atherosclerosis. Circulation 103: 1503-1508 [Abstract] [Full Text]  
• Schiele, F, Batur, M K, Seronde, M F, Meneveau, N, Sewoke, P, Bassignot, A, Couetdic, G, Caulfield, F, Bassand, J-P (2001). Cytomegalovirus, Chlamydia pneumoniae, and Helicobacter pylori IgG antibodies and restenosis after stent implantation: an angiographic and intravascular ultrasound study. Heart 85: 304-311 [Abstract] [Full Text]  
• Zhu, J., Nieto, F. J., Horne, B. D., Anderson, J. L., Muhlestein, J. B., Epstein, S. E. (2001). Prospective Study of Pathogen Burden and Risk of Myocardial Infarction or Death. Circulation 103: 45-51 [Abstract] [Full Text]  
• Naghavi, M., Barlas, Z., Siadaty, S., Naguib, S., Madjid, M., Casscells, W. (2000). Association of Influenza Vaccination and Reduced Risk of Recurrent Myocardial Infarction. Circulation 102: 3039-3045 [Abstract] [Full Text]  
• Muhlestein, J. B., Horne, B. D., Carlquist, J. F., Madsen, T. E., Bair, T. L., Pearson, R. R., Anderson, J. L. (2000). Cytomegalovirus Seropositivity and C-Reactive Protein Have Independent and Combined Predictive Value for Mortality in Patients With Angiographically Demonstrated Coronary Artery Disease. Circulation 102: 1917-1923 [Abstract] [Full Text]  
• Castillo, J. P., Yurochko, A. D., Kowalik, T. F. (2000). Role of Human Cytomegalovirus Immediate-Early Proteins in Cell Growth Control. J. Virol. 74: 8028-8037 [Abstract] [Full Text]  
• Espinola-Klein, C., Rupprecht, H.-J., Blankenberg, S., Bickel, C., Kopp, H., Rippin, G., Hafner, G., Pfeifer, U., Meyer, J. (2000). Are Morphological or Functional Changes in the Carotid Artery Wall Associated With Chlamydia pneumoniae, Helicobacter pylori, Cytomegalovirus, or Herpes Simplex Virus Infection?. Stroke 31: 2127-2133 [Abstract] [Full Text]  
• Alber, D. G., Powell, K. L., Vallance, P., Goodwin, D. A., Grahame-Clarke, C. (2000). Herpesvirus Infection Accelerates Atherosclerosis in the Apolipoprotein E-Deficient Mouse. Circulation 102: 779-785 [Abstract] [Full Text]  
• Fong, I. W. (2000). Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. CMAJ 163: 49-56 [Abstract] [Full Text]  
• Camm, A.J., Fox, K.M. (2000). Chlamydia pneumonia (and other infective agents) in atherosclerosis and acute coronary syndromes. How good is the evidence?. Eur Heart J 21: 1046-1051  
• GRIMES, D.S., HINDLE, E., DYER, T. (2000). Respiratory infection and coronary heart disease: progression of a paradigm. QJM 93: 375-383 [Abstract] [Full Text]  
• Epstein, S. E., Zhu, J., Burnett, M. S., Zhou, Y. F., Vercellotti, G., Hajjar, D. (2000). Infection and Atherosclerosis : Potential Roles of Pathogen Burden and Molecular Mimicry. Arterioscler. Thromb. Vasc. Bio. 20: 1417-1420 [Abstract] [Full Text]  
• Moreno, P. R., Palacios, I. F. (2000). Cytomegalovirus and Restenosis After Percutaneous Transluminal Coronary Angioplasty. Circulation 101 : e163-e163 [Full Text]  
• Matsushita, H., Morishita, R., Aoki, M., Tomita, N., Taniyama, Y., Nakagami, H., Shimozato, T., Higaki, J., Kaneda, Y., Ogihara, T. (2000). Transfection of Antisense p53 Tumor Suppressor Gene Oligodeoxynucleotides Into Rat Carotid Artery Results in Abnormal Growth of Vascular Smooth Muscle Cells. Circulation 101: 1447-1452 [Abstract] [Full Text]  
• Zhou, Y. F., Shou, M., Harrell, R. F, Yu, Z. X., Unger, E. F, Epstein, S. E (2000). Chronic non-vascular cytomegalovirus infection: effects on the neointimal response to experimental vascular injury. Cardiovasc Res 45: 1019-1025 [Abstract] [Full Text]  
• Kotenko, S. V., Saccani, S., Izotova, L. S., Mirochnitchenko, O. V., Pestka, S. (2000). Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl. Acad. Sci. USA 97: 1695-1700 [Abstract] [Full Text]  
• Roivainen, M., Viik-Kajander, M., Palosuo, T., Toivanen, P., Leinonen, M., Saikku, P., Tenkanen, L., Manninen, V., Hovi, T., Manttari, M. (2000). Infections, Inflammation, and the Risk of Coronary Heart Disease. Circulation 101: 252-257 [Abstract] [Full Text]  
• Neumann, F.-J., Kastrati, A., Miethke, T., Pogatsa-Murray, G., Seyfarth, M., Schomig, A. (2000). Previous Cytomegalovirus Infection and Risk of Coronary Thrombotic Events After Stent Placement. Circulation 101: 11-13 [Abstract] [Full Text]  
• Baldwin, B. R., Zhang, C.-O., Keay, S. (2000). Cloning and epitope mapping of a functional partial fusion receptor for human cytomegalovirus gH. J. Gen. Virol. 81: 27-35 [Abstract] [Full Text]  
• Wiedermann, C. J., Kiechl, S., Dunzendorfer, S., Schratzberger, P., Egger, G., Oberhollenzer, F., Willeit, J. (1999). Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: Prospective results from the bruneck study. J Am Coll Cardiol 34: 1975-1981 [Abstract] [Full Text]  
• Zhu, J., Quyyumi, A. A., Norman, J. E., Csako, G., Epstein, S. E. (1999). Cytomegalovirus in the pathogenesis of atherosclerosis: The role of inflammation as reflected by elevated C-reactive protein levels. J Am Coll Cardiol 34: 1738-1743 [Abstract] [Full Text]  
• Chung, M., Kizhatil, K., Albritton, L. M., Gaulton, G. N. (1999). Induction of Syncytia by Neuropathogenic Murine Leukemia Viruses Depends on Receptor Density, Host Cell Determinants, and the Intrinsic Fusion Potential of Envelope Protein. J. Virol. 73: 9377-9385 [Abstract] [Full Text]  
• Rossignol, D. A., Kipreos, B., Akosah, K., Mohanty, P. K. (1999). Accelerated Transplant Coronary Artery Disease and Massive Silent Acute Myocardial Infarction in a Heart Transplant Patient: A Case Report and Brief Review of Literature. ANGIOLOGY 50: 947-953 [Abstract]  
• Zhou, Y. F., Shou, M., Guetta, E., Guzman, R., Unger, E. F., Yu, Z. X., Zhang, J., Finkel, T., Epstein, S. E. (1999). Cytomegalovirus Infection of Rats Increases the Neointimal Response to Vascular Injury Without Consistent Evidence of Direct Infection of the Vascular Wall. Circulation 100: 1569-1575 [Abstract] [Full Text]  
• Aoki, M., Morishita, R., Matsushita, H., Hayashi, S.-i., Nakagami, H., Yamamoto, K., Moriguchi, A., Kaneda, Y., Higaki, J., Ogihara, T. (1999). Inhibition of the p53 Tumor Suppressor Gene Results in Growth of Human Aortic Vascular Smooth Muscle Cells : Potential Role of p53 in Regulation of Vascular Smooth Muscle Cell Growth. Hypertension 34: 192-200 [Abstract] [Full Text]  
• Epstein, S. E., Zhou, Y. F., Zhu, J. (1999). Infection and Atherosclerosis : Emerging Mechanistic Paradigms. Circulation 100 : e20-e28 [Abstract] [Full Text]  
• Valantine, H. A., Gao, S.-Z., Menon, S. G., Renlund, D. G., Hunt, S. A., Oyer, P., Stinson, E. B., Brown, B. W. Jr, Merigan, T. C., Schroeder, J. S. (1999). Impact of Prophylactic Immediate Posttransplant Ganciclovir on Development of Transplant Atherosclerosis : A Post Hoc Analysis of a Randomized, Placebo-Controlled Study. Circulation 100: 61-66 [Abstract] [Full Text]  
• Tanaka, K., Zou, J.-P., Takeda, K., Ferrans, V. J., Sandford, G. R., Johnson, T. M., Finkel, T., Epstein, S. E. (1999). Effects of Human Cytomegalovirus Immediate-Early Proteins on p53-mediated Apoptosis in Coronary Artery Smooth Muscle Cells. Circulation 99: 1656-1659 [Abstract] [Full Text]  
• Bertrand, M. E., Bauters, C. (1999). Cytomegalovirus Infection and Coronary Restenosis. Circulation 99: 1278-1279 [Full Text]  
• Manegold, C., Alwazzeh, M., Jablonowski, H., Adams, O., Medve, M., Seidlitz, B., Heidland, U., Haussinger, D., Strauer, B.-E., Heintzen, M. P. (1999). Prior Cytomegalovirus Infection and the Risk of Restenosis After Percutaneous Transluminal Coronary Balloon Angioplasty. Circulation 99: 1290-1294 [Abstract] [Full Text]  
• Bartels, C., Maass, M., Bein, G., Malisius, R., Brill, N., Bechtel, J. F. M., Sayk, F., Feller, A. C., Sievers, H.-H. (1999). Detection of Chlamydia pneumoniae But Not Cytomegalovirus in Occluded Saphenous Vein Coronary Artery Bypass Grafts. Circulation 99: 879-882 [Abstract] [Full Text]  
• Pahor, M., Elam, M. B., Garrison, R. J., Kritchevsky, S. B., Applegate, W. B. (1999). Emerging Noninvasive Biochemical Measures to Predict Cardiovascular Risk. Arch Intern Med 159: 237-245 [Abstract] [Full Text]  
• HALLORAN, P. F., MELK, A., BARTH, C. (1999). Rethinking Chronic Allograft Nephropathy: The Concept of AcceleratedSenescence. J. Am. Soc. Nephrol. 10: 167-181 [Full Text]  
• Ridker, P. M., Hennekens, C. H., Stampfer, M. J., Wang, F. (1998). Prospective Study of Herpes Simplex Virus, Cytomegalovirus, and the Risk of Future Myocardial Infarction and Stroke. Circulation 98: 2796-2799 [Abstract] [Full Text]  
• Caligiuri, G., Liuzzo, G., Biasucci, L. M., Maseri, A. (1998). Immune system activation follows inflammation in unstable angina: pathogenetic implications. J Am Coll Cardiol 32: 1295-1304 [Abstract] [Full Text]  
• Presti, R. M., Pollock, J. L., Dal Canto, A. J., O'Guin, A. K., Virgin, H. W. IV (1998). Interferon {gamma} Regulates Acute and Latent Murine Cytomegalovirus Infection and Chronic Disease of the Great Vessels. JEM 188: 577-588 [Abstract] [Full Text]  
• Speir, E., Yu, Z.-X., Ferrans, V. J., Huang, E.-S., Epstein, S. E. (1998). Aspirin Attenuates Cytomegalovirus Infectivity and Gene Expression Mediated by Cyclooxygenase-2 in Coronary Artery Smooth Muscle Cells. Circ. Res. 83: 210-216 [Abstract] [Full Text]  
• Anderson, J. L., Carlquist, J. F., Muhlestein, J. B., Horne, B. D., Elmer, S. P. (1998). Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol 32: 35-41 [Abstract] [Full Text]  
• Kastrati, A., Schomig, A., Elezi, S., Schuhlen, H., Wilhelm, M., Dirschinger, J. (1998). Interlesion Dependence of the Risk for Restenosis in Patients With Coronary Stent Placement in Multiple Lesions. Circulation 97: 2396-2401 [Abstract] [Full Text]  
• Krosky, P. M., Underwood, M. R., Turk, S. R., Feng, K. W.-H., Jain, R. K., Ptak, R. G., Westerman, A. C., Biron, K. K., Townsend, L. B., Drach, J. C. (1998). Resistance of Human Cytomegalovirus to Benzimidazole Ribonucleosides Maps to Two Open Reading Frames: UL89 and UL56. J. Virol. 72: 4721-4728 [Abstract] [Full Text]  
• Ridker, P. M. (1998). Inflammation, Infection, and Cardiovascular Risk : How Good Is the Clinical Evidence?. Circulation 97: 1671-1674 [Full Text]  
• Nicholson, A. C., Hajjar, D. P. (1998). Herpesviruses in Atherosclerosis and Thrombosis : Etiologic Agents or Ubiquitous Bystanders?. Arterioscler. Thromb. Vasc. Bio. 18: 339-348 [Abstract] [Full Text]  
• Kritchevsky, D. (1998). History of Recommendations to the Public about Dietary Fat. J. Nutr. 128: 449-449 [Abstract] [Full Text]  
• Sutherland, M. R., Raynor, C. M., Leenknegt, H., Wright, J. F., Pryzdial, E. L. G. (1997). Coagulation initiated on herpesviruses. Proc. Natl. Acad. Sci. USA 94: 13510-13514 [Abstract] [Full Text]  
• Libby, P., Egan, D., Skarlatos, S. (1997). Roles of Infectious Agents in Atherosclerosis and Restenosis: An Assessment of the Evidence and Need for Future Research. Circulation 96: 4095-4103 [Full Text]